In essence, inflammation has been shown to decrease intestinal GLUT5 activity and mRNA expression in murine models;63 similarly, in SSc patients, histological analyses of biopsy specimens have shown mononuclear inflammatory cells within intestinal wall. This evidence concerns the gene SLC2A5 and systemic sclerosis.